mouse anti human cd133 Search Results


95
Miltenyi Biotec cd133/1 antibody, anti-human
Cd133/1 Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+human+cd133/CD133%2F1+Antibody%2C+anti-human/custom%40130-108-062%4026788141
Average 95 stars, based on 1 article reviews
cd133/1 antibody, anti-human - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Diagnostica Stago mouse anti-human cd133 antibody
Characteristics of CD34 + VEGFR-3 + EPCs. (A) There are CD34 + VEGFR-3 + cells and <t>CD133</t> + VEGFR-3 + cells in the mononuclear cells isolated from umbilical cord blood. The cells were analyzed with a flow cytometer. (B) In immunostaining, VEGFR-3 + cells express CD34 and CD133. (C) Features of CD34 + VEGFR-3 + EPCs. After treatment with 50 ng/ml VEGF-C, the cells proliferate, the shape of the cells changes. (D) Expression of LYVE-1 on the differentiated cells. At day 14 after induction with VEGF-C, the cells are positive for LYVE-1 immunostaining. Bars = 25 μm.
Mouse Anti Human Cd133 Antibody, supplied by Diagnostica Stago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+human+cd133/mouse+anti+human+cd133+antibody/pmc03920171-68-26-31
Average 90 stars, based on 1 article reviews
mouse anti-human cd133 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bioworld Antibodies mouse anti-human cd133 antibody
Cell ball with positive cluster of differentiation 133 staining via fluorescence microscopy (magnification, ×200).
Mouse Anti Human Cd133 Antibody, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+human+cd133/mouse+anti+human+cd133+antibody/pmc06202534-72-13-21
Average 90 stars, based on 1 article reviews
mouse anti-human cd133 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Exbio Praha pe-conjugated mouse anti-human cd133
Stem cell-enriched spheroid model (SCESM) spheroid growth condition analysis. Growth of SCESM spheroids with three different cell seeding concentrations, i.e., 3500, 2500, and 1500 cells per well, was analyzed and relative gene expression of head and neck squamous cell carcinoma (HNSCC) stem markers was assessed; ( a ) Growth curve of SCESM spheroids cultured for 11 days. Mean values ± SE ( n = 4) are presented, (*, ∆, and o represent p < 0.05, * is used for comparisons in group 1500 c./well, ∆ is used for comparisons in group 2500 c./well, o is used for comparisons in group 3500 c./well); ( b – d ) Relative gene expression of stem markers in 7-day-old SCESM spheroids and an adherent cell line. Normalized mean values ± SE ( n ≥ 4) are presented. Asterisks above the graph bars represent the results of statistical analysis of the studied group vs. the control group—adh (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001); ( b ) Relative gene expression of ALDH1A1 ; ( c ) Relative gene expression of CD44 ; ( d ) Relative gene expression of <t>PROM1</t> . adh, adherent cell line.
Pe Conjugated Mouse Anti Human Cd133, supplied by Exbio Praha, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+human+cd133/pe+conjugated+mouse+anti+human+cd133/pmc07408407-63-25-30
Average 90 stars, based on 1 article reviews
pe-conjugated mouse anti-human cd133 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ETERLIFE LTD cd133-fitc antibody
Stem cell-enriched spheroid model (SCESM) spheroid growth condition analysis. Growth of SCESM spheroids with three different cell seeding concentrations, i.e., 3500, 2500, and 1500 cells per well, was analyzed and relative gene expression of head and neck squamous cell carcinoma (HNSCC) stem markers was assessed; ( a ) Growth curve of SCESM spheroids cultured for 11 days. Mean values ± SE ( n = 4) are presented, (*, ∆, and o represent p < 0.05, * is used for comparisons in group 1500 c./well, ∆ is used for comparisons in group 2500 c./well, o is used for comparisons in group 3500 c./well); ( b – d ) Relative gene expression of stem markers in 7-day-old SCESM spheroids and an adherent cell line. Normalized mean values ± SE ( n ≥ 4) are presented. Asterisks above the graph bars represent the results of statistical analysis of the studied group vs. the control group—adh (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001); ( b ) Relative gene expression of ALDH1A1 ; ( c ) Relative gene expression of CD44 ; ( d ) Relative gene expression of <t>PROM1</t> . adh, adherent cell line.
Cd133 Fitc Antibody, supplied by ETERLIFE LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+human+cd133/mouse+anti+human+cd133+fitc+antibody/pmc06773227-63-38-40
Average 90 stars, based on 1 article reviews
cd133-fitc antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier








Image Search Results


Characteristics of CD34 + VEGFR-3 + EPCs. (A) There are CD34 + VEGFR-3 + cells and CD133 + VEGFR-3 + cells in the mononuclear cells isolated from umbilical cord blood. The cells were analyzed with a flow cytometer. (B) In immunostaining, VEGFR-3 + cells express CD34 and CD133. (C) Features of CD34 + VEGFR-3 + EPCs. After treatment with 50 ng/ml VEGF-C, the cells proliferate, the shape of the cells changes. (D) Expression of LYVE-1 on the differentiated cells. At day 14 after induction with VEGF-C, the cells are positive for LYVE-1 immunostaining. Bars = 25 μm.

Journal: International Journal of Biological Sciences

Article Title: Inhibition of Lymphangiogenesis of Endothelial Progenitor Cells with VEGFR-3 siRNA Delivered with PEI-alginate Nanoparticles

doi: 10.7150/ijbs.6719

Figure Lengend Snippet: Characteristics of CD34 + VEGFR-3 + EPCs. (A) There are CD34 + VEGFR-3 + cells and CD133 + VEGFR-3 + cells in the mononuclear cells isolated from umbilical cord blood. The cells were analyzed with a flow cytometer. (B) In immunostaining, VEGFR-3 + cells express CD34 and CD133. (C) Features of CD34 + VEGFR-3 + EPCs. After treatment with 50 ng/ml VEGF-C, the cells proliferate, the shape of the cells changes. (D) Expression of LYVE-1 on the differentiated cells. At day 14 after induction with VEGF-C, the cells are positive for LYVE-1 immunostaining. Bars = 25 μm.

Article Snippet: The mononuclear cells were incubated with mouse anti-human CD34 antibody (1:100; Diagnostica, NJ, USA) and rabbit anti-human VEGFR-3 antibody (1:100; Santa Cruz Biotechnology, CA, USA), or mouse anti-human CD133 antibody (1:100; Diagnostica, NJ, USA) and rabbit anti-human VEGFR-3 antibody (1:100) at 4°C for 50 min. Nonspecific antigen of the cells was blocked with 5% bovine serum albumin (BSA; GE Healthcare, London, UK).

Techniques: Isolation, Flow Cytometry, Immunostaining, Expressing

Cell ball with positive cluster of differentiation 133 staining via fluorescence microscopy (magnification, ×200).

Journal: Oncology Letters

Article Title: Effects of NOTCH1 signaling inhibitor γ-secretase inhibitor II on growth of cancer stem cells

doi: 10.3892/ol.2018.9377

Figure Lengend Snippet: Cell ball with positive cluster of differentiation 133 staining via fluorescence microscopy (magnification, ×200).

Article Snippet: Antibodies included rabbit anti-human Nestin antibody (cat. no. n5413; 1:100; Sigma-Aldrich; Merck KGaA), mouse anti-human CD133 antibody (cat. no. o43490; 1:500; Bioworld Technology, Inc., St. Louis Park, MN, USA), Cy3-labeled goat anti-mouse antibody (cat. no. BA103; 1:100; Wuhan Boster Biological Technology, Ltd.), fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit antibody (cat. no. BA1105; 1:50; Wuhan Boster Biological Technology, Ltd.), and rabbit anti-human glial fibrillary acidic protein antibody (GFAP; cat. no. {"type":"entrez-protein","attrs":{"text":"PAB18435","term_id":"1236631376","term_text":"PAB18435"}} PAB18435 ; 1:500; Abnova, Tapei, Taiwan).

Techniques: Staining, Fluorescence, Microscopy

Stem cell-enriched spheroid model (SCESM) spheroid growth condition analysis. Growth of SCESM spheroids with three different cell seeding concentrations, i.e., 3500, 2500, and 1500 cells per well, was analyzed and relative gene expression of head and neck squamous cell carcinoma (HNSCC) stem markers was assessed; ( a ) Growth curve of SCESM spheroids cultured for 11 days. Mean values ± SE ( n = 4) are presented, (*, ∆, and o represent p < 0.05, * is used for comparisons in group 1500 c./well, ∆ is used for comparisons in group 2500 c./well, o is used for comparisons in group 3500 c./well); ( b – d ) Relative gene expression of stem markers in 7-day-old SCESM spheroids and an adherent cell line. Normalized mean values ± SE ( n ≥ 4) are presented. Asterisks above the graph bars represent the results of statistical analysis of the studied group vs. the control group—adh (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001); ( b ) Relative gene expression of ALDH1A1 ; ( c ) Relative gene expression of CD44 ; ( d ) Relative gene expression of PROM1 . adh, adherent cell line.

Journal: Cells

Article Title: Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening

doi: 10.3390/cells9071707

Figure Lengend Snippet: Stem cell-enriched spheroid model (SCESM) spheroid growth condition analysis. Growth of SCESM spheroids with three different cell seeding concentrations, i.e., 3500, 2500, and 1500 cells per well, was analyzed and relative gene expression of head and neck squamous cell carcinoma (HNSCC) stem markers was assessed; ( a ) Growth curve of SCESM spheroids cultured for 11 days. Mean values ± SE ( n = 4) are presented, (*, ∆, and o represent p < 0.05, * is used for comparisons in group 1500 c./well, ∆ is used for comparisons in group 2500 c./well, o is used for comparisons in group 3500 c./well); ( b – d ) Relative gene expression of stem markers in 7-day-old SCESM spheroids and an adherent cell line. Normalized mean values ± SE ( n ≥ 4) are presented. Asterisks above the graph bars represent the results of statistical analysis of the studied group vs. the control group—adh (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001); ( b ) Relative gene expression of ALDH1A1 ; ( c ) Relative gene expression of CD44 ; ( d ) Relative gene expression of PROM1 . adh, adherent cell line.

Article Snippet: Cells were then labeled overnight at 4 °C with primary monoclonal antibodies: PerCP-Cyanine5.5-conjugated rat anti-human CD44 (#45-0441-82, ThermoFisher Scientific), PE-conjugated mouse anti-human CD73 (#1P-675-T100, ExBio), PE-conjugated mouse anti-human CD133 (#1P-819-T100, ExBio), and mouse anti-human CD90 (#sc-53456, SCBT, Dallas, TX, USA).

Techniques: Expressing, Cell Culture

Protein expression of stem markers. The protein expression of five different stem markers was assessed in the FaDu adherent cell line and 7-day-old SCESM spheroids by Western blot and flow cytometry. ( a – d ) Protein expression analyzed by flow cytometry. Normalized fluorescence intensities of selected proteins are presented, and corresponding flow cytometry visible light and fluorescent photos are attached. Normalized mean values ± SE ( n ≥ 5, N ≥ 2000) are presented (**** p < 0.0001 vs. control (adh)); ( a ) CD44 protein expression; ( b ) CD73 protein expression; ( c ) CD90 protein expression; ( d ) CD133 protein expression; ( e ) OCT4 and tubulin protein expression analyzed by Western blot. Western blot membrane photos showing OCT4 and tubulin and a graph depicting normalized OCT4 protein expression analysis from Western blots are presented. Bars represent normalized mean values ± SE ( n ≥ 3). B: blank; adh: adherent cell line; S: SCESM.

Journal: Cells

Article Title: Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening

doi: 10.3390/cells9071707

Figure Lengend Snippet: Protein expression of stem markers. The protein expression of five different stem markers was assessed in the FaDu adherent cell line and 7-day-old SCESM spheroids by Western blot and flow cytometry. ( a – d ) Protein expression analyzed by flow cytometry. Normalized fluorescence intensities of selected proteins are presented, and corresponding flow cytometry visible light and fluorescent photos are attached. Normalized mean values ± SE ( n ≥ 5, N ≥ 2000) are presented (**** p < 0.0001 vs. control (adh)); ( a ) CD44 protein expression; ( b ) CD73 protein expression; ( c ) CD90 protein expression; ( d ) CD133 protein expression; ( e ) OCT4 and tubulin protein expression analyzed by Western blot. Western blot membrane photos showing OCT4 and tubulin and a graph depicting normalized OCT4 protein expression analysis from Western blots are presented. Bars represent normalized mean values ± SE ( n ≥ 3). B: blank; adh: adherent cell line; S: SCESM.

Article Snippet: Cells were then labeled overnight at 4 °C with primary monoclonal antibodies: PerCP-Cyanine5.5-conjugated rat anti-human CD44 (#45-0441-82, ThermoFisher Scientific), PE-conjugated mouse anti-human CD73 (#1P-675-T100, ExBio), PE-conjugated mouse anti-human CD133 (#1P-819-T100, ExBio), and mouse anti-human CD90 (#sc-53456, SCBT, Dallas, TX, USA).

Techniques: Expressing, Western Blot, Flow Cytometry, Fluorescence

Comparative analysis of SCESM spheroids and multi-cellular tumor spheroids (MCTSs). ( a ) Graph representing SCESM spheroid and MCTS mean diameter increase. Spheroids were photographed on days 2, 4, and 7 and representative phase-contrast microscope images of SCESM spheroids and MCTSs on days 2, 4, and 7 are displayed under the graph. Mean values ± SE ( n ≥ 8) are presented. Scale bars correspond to 400 µm; ( b – e ) Protein expression of four different stem markers was assessed in SCESM spheroids and MCTSs by flow cytometry. Normalized fluorescence intensities of selected proteins are presented and corresponding flow cytometry visible light and fluorescent photos are attached ( n ≥ 5, N ≥ 2000); (b) CD44 protein expression; ( c ) CD73 protein expression; ( d ) CD90 protein expression; ( e ) CD133 protein expression; ( f ) OCT4 and tubulin protein expressions were assessed in SCESM spheroids and MCTSs by Western blot analysis. Western blot membrane photo showing OCT4 and tubulin and graph depicting normalized OCT4 protein expression analysis from Western blots (using Image Lab software) are presented ( n ≥ 3); ( g – i ) Relative gene expression of three additional stem markers assessed in 7-day-old MCTSs and SCESM spheroids; Normalized mean values ± SE ( n ≥ 5) are presented; ( g ) Relative gene expression of ALDH1A1 ; ( h ) Relative gene expression of NANOG ; ( i ) Relative gene expression of SOX2 . (* p < 0.05, **** p < 0.0001 vs. control (MCTS)). B: blank; M: multi-cellular tumor spheroid; S: SCESM.

Journal: Cells

Article Title: Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening

doi: 10.3390/cells9071707

Figure Lengend Snippet: Comparative analysis of SCESM spheroids and multi-cellular tumor spheroids (MCTSs). ( a ) Graph representing SCESM spheroid and MCTS mean diameter increase. Spheroids were photographed on days 2, 4, and 7 and representative phase-contrast microscope images of SCESM spheroids and MCTSs on days 2, 4, and 7 are displayed under the graph. Mean values ± SE ( n ≥ 8) are presented. Scale bars correspond to 400 µm; ( b – e ) Protein expression of four different stem markers was assessed in SCESM spheroids and MCTSs by flow cytometry. Normalized fluorescence intensities of selected proteins are presented and corresponding flow cytometry visible light and fluorescent photos are attached ( n ≥ 5, N ≥ 2000); (b) CD44 protein expression; ( c ) CD73 protein expression; ( d ) CD90 protein expression; ( e ) CD133 protein expression; ( f ) OCT4 and tubulin protein expressions were assessed in SCESM spheroids and MCTSs by Western blot analysis. Western blot membrane photo showing OCT4 and tubulin and graph depicting normalized OCT4 protein expression analysis from Western blots (using Image Lab software) are presented ( n ≥ 3); ( g – i ) Relative gene expression of three additional stem markers assessed in 7-day-old MCTSs and SCESM spheroids; Normalized mean values ± SE ( n ≥ 5) are presented; ( g ) Relative gene expression of ALDH1A1 ; ( h ) Relative gene expression of NANOG ; ( i ) Relative gene expression of SOX2 . (* p < 0.05, **** p < 0.0001 vs. control (MCTS)). B: blank; M: multi-cellular tumor spheroid; S: SCESM.

Article Snippet: Cells were then labeled overnight at 4 °C with primary monoclonal antibodies: PerCP-Cyanine5.5-conjugated rat anti-human CD44 (#45-0441-82, ThermoFisher Scientific), PE-conjugated mouse anti-human CD73 (#1P-675-T100, ExBio), PE-conjugated mouse anti-human CD133 (#1P-819-T100, ExBio), and mouse anti-human CD90 (#sc-53456, SCBT, Dallas, TX, USA).

Techniques: Microscopy, Expressing, Flow Cytometry, Fluorescence, Western Blot, Software